Ausgabe 1/2011
Inhalt (28 Artikel)
It's hard to keep all things angiogenic in one JAR!
Jan Kitajewski, Yihai Cao, Mark Slevin
Notch modulates VEGF action in endothelial cells by inducing Matrix Metalloprotease activity
Yasuhiro Funahashi, Carrie J Shawber, Anshula Sharma, Emi Kanamaru, Yun K Choi, Jan Kitajewski
Nanotechnology-mediated targeting of tumor angiogenesis
Deboshri Banerjee, Rania Harfouche, Shiladitya Sengupta
Dermal fibroblasts display similar phenotypic and differentiation capacity to fat-derived mesenchymal stem cells, but differ in anti-inflammatory and angiogenic potential
Antonella Blasi, Carmela Martino, Luigi Balducci, Marilisa Saldarelli, Antonio Soleti, Stefania E Navone, Laura Canzi, Silvia Cristini, Gloria Invernici, Eugenio A Parati, Giulio Alessandri
Complementary effects of extracellular nucleotides and platelet-derived extracts on angiogenesis of vasa vasorum endothelial cells in vitro and subcutaneous Matrigel plugs in vivo
Mark Roedersheimer, Hala Nijmeh, Nana Burns, Asya A Sidiakova, Kurt R Stenmark, Evgenia V Gerasimovskaya
Changes in expression of VE-cadherin and MMPs in endothelial cells: Implications for angiogenesis
Manikantan S Kiran, Raveendran I Viji, Sameer VB Kumar, Athira A Prabhakaran, Perumana R Sudhakaran
Vaccines targeting the neovasculature of tumors
Agata Matejuk, Qixin Leng, Szu-Ting Chou, Archibald J Mixson
The role of AMP-activated protein kinase in the functional effects of vascular endothelial growth factor-A and -B in human aortic endothelial cells
James A Reihill, Marie-Ann Ewart, Ian P Salt
Nanotechnology for the treatment of coronary in stent restenosis: a clinical perspective
Garry McDowell, Mark Slevin, Jerzy Krupinski
A deficiency of uPAR alters endothelial angiogenic function and cell morphology
Rashna D Balsara, Reid Merryman, Farhaad Virjee, Claire Northway, Francis J Castellino, Victoria A Ploplis
Angiogenic potential of endothelial progenitor cells and embryonic stem cells
Peter C Rae, Richard DW Kelly, Stuart Egginton, Justin C St John
Low doses of 3-aminobenzamide, a poly(ADP-ribose) polymerase inhibitor, stimulate angiogenesis by regulating expression of urokinase type plasminogen activator and matrix metalloprotease 2
Riccardo Caldini, Elena Fanti, Lucia Magnelli, Emanuela Barletta, Elisabetta Tanganelli, Michele Zampieri, Marta Chevanne
Effects on duration of post-operative ischemia and patterns of blood flow recovery in different conditions of mouse hind limb ischemia
Husain A Al-Mubarak, Talal M Alamri, Saif A Aljabab, Mohammad Atteya, Adrian Quan, Hwee Teoh, Praphulla C Shukla, Subodh Verma, Abdullah Aldahmash, Badr Aljabri, Claudio Napoli, Mohammed Al-Omran
Insulin-Like Growth Factor-1 (IGF-1) Reduces ischemic changes and increases circulating angiogenic factors in experimentally - induced myocardial infarction in rats
Mathews Lisa, Nagaraja Haleagrahara, Srikumar Chakravarthi
Phase I study of telatinib (BAY 57-9352): analysis of safety, pharmacokinetics, tumor efficacy, and biomarkers in patients with colorectal cancer
Klaus Mross, Annette Frost, Max E Scheulen, Jürgen Krauss, Dirk Strumberg, Beate Schultheiss, Ulrike Fasol, Martin Büchert, Jörn Krätzschmer, Heinz Delesen, Prabhu Rajagopalan, Olaf Christensen
Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis
Shakil Ahmad, Peter W Hewett, Bahjat Al-Ani, Samir Sissaoui, Takeshi Fujisawa, Melissa J Cudmore, Asif Ahmed
Anti-DLL4, a cancer therapeutic with multiple mechanisms of action
Austin Gurney, Timothy Hoey
Expression of HES and HEY genes in infantile hemangiomas
Omotinuwe Adepoju, Alvin Wong, Alex Kitajewski, Karen Tong, Elisa Boscolo, Joyce Bischoff, Jan Kitajewski, June K Wu
Cyclic strain upregulates VEGF and attenuates proliferation of vascular smooth muscle cells
Joseph F Schad, Kate R Meltzer, Michael R Hicks, David S Beutler, Thanh V Cao, Paul R Standley
Dll4-Notch signaling as a therapeutic target in tumor angiogenesis
Frank Kuhnert, Jessica R Kirshner, Gavin Thurston
Inhibition of cyclo-oxygenase 2 reduces tumor metastasis and inflammatory signaling during blockade of vascular endothelial growth factor
Jason C Fisher, Jeffrey W Gander, Mary Jo Haley, Sonia L Hernandez, Jianzhong Huang, Yan-Jung Chang, Tessa B Johung, Paolo Guarnieri, Kathleen O'Toole, Darrell J Yamashiro, Jessica J Kandel
Challenges in translating vascular tissue engineering to the pediatric clinic
Daniel R Duncan, Christopher K Breuer
The role of microRNAs in neural stem cell-supported endothelial morphogenesis
Tamara Roitbak, Olga Bragina, Jamie L Padilla, Gavin G Pickett
Nanoparticle mediated targeting of VEGFR and cancer stem cells for cancer therapy
Rashmi K Ambasta, Archita Sharma, Pravir Kumar
Application of microtechnologies for the vascularization of engineered tissues
Robert Gauvin, Maxime Guillemette, Mehmet Dokmeci, Ali Khademhosseini
Co-culture of Retinal and Endothelial Cells Results in the Modulation of Genes Critical to Retinal Neovascularization
Ravindra Kumar, Sandra Harris-Hooker, Ritesh Kumar, Gary Sanford
Lymphoid enhancer-binding factor 1, a representative of vertebrate-specific Lef1/Tcf1 sub-family, is a Wnt-beta-catenin pathway target gene in human endothelial cells which regulates matrix metalloproteinase-2 expression and promotes endothelial cell invasion
Marina Planutiene, Kestutis Planutis, Randall F Holcombe